Clinical Trial Update: OnabotulinumtoxinA Injections in Chronic Migraine, Targeted to Sites of Pericranial Myofascial Pain

View source ↗

Summary

A completed clinical trial evaluated OnabotulinumtoxinA injections targeted to pericranial myofascial pain sites in chronic migraine patients. The study was spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Chronic Migraine | Status: COMPLETED